Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center Stage

por Mehta, Heena, Angsana, Julianty, Bissonnette, Robert, Muñoz-Elías, Ernesto J., Sarfati, Marika
Publicado 2021

The biological basis of disease recurrence in psoriasis: a historical perspective and current models

por Puig, Lluís, Costanzo, Antonio, Muñoz‐Elías, Ernesto J., Jazra, Maria, Wegner, Sven, Paul, Carle F., Conrad, Curdin
Publicado 2022

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

por Tarcha, Eric J., Olsen, Chelsea M., Probst, Peter, Peckham, David, Muñoz-Elías, Ernesto J., Kruger, James G., Iadonato, Shawn P.
Publicado 2017

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants...

por Eyerich, Kilian, Weisenseel, Peter, Pinter, Andreas, Schäkel, Knut, Asadullah, Khusru, Wegner, Sven, Muñoz-Elias, Ernesto J, Bartz, Holger, Taut, Friedmann J H, Reich, Kristian
Publicado 2021

Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis

por Land, Judith, Lintermans, Lucas L., Stegeman, Coen A., Muñoz-Elías, Ernesto J., Tarcha, Eric J., Iadonato, Shawn P., Heeringa, Peter, Rutgers, Abraham, Abdulahad, Wayel H.
Publicado 2017